Trials / Completed
CompletedNCT02538848
Study of HTD4010 in Healthy Volunteers
A First in Human, Randomized, Double-Blind Study to Assess Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Effects of HTD4010 in Healthy Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- HighTide Biopharma Pty Ltd · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
To investigate safety and tolerability of HTD4010 after single ascending doses (SAD) in healthy volunteers
Detailed description
Safety, tolerability and pharmacokinetics(PK) assessments are the outcome measure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HTD4010 | injectable solution |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2015-09-02
- Last updated
- 2020-07-27
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT02538848. Inclusion in this directory is not an endorsement.